Table 4.
Multivariate linear models for CA125 prediction among non-mucinous invasive post-op study cases.
| Model 1 | Model 2 | |||
|---|---|---|---|---|
| Estimate | p-value | Estimate | p-value | |
| Age (years) | 0.13 | 0.04 | 0.06 | 0.26 |
| Age (years), squared | −0.001 | 0.04 | −0.001 | 0.24 |
| Jewish | 0.45 | 0.07 | 0.37 | 0.09 |
| BMI (quintiles) | −0.03 | 0.06 | −0.02 | 0.09 |
| Parity (continuous) | 0.14 | 0.01 | 0.09 | 0.07 |
| Yeast infections | −1.62 | 0.02 | −1.49 | 0.01 |
| Appendectomy | −0.45 | 0.03 | −0.50 | 0.008 |
| Colitis | −1.03 | 0.07 | −0.65 | 0.19 |
| History of breast cancer | 0.88 | 0.004 | 0.87 | 0.002 |
| Endometrioid/clear cell (vs. serous) | −0.94 | <0.0001 | 0.02 | 0.91 |
| Mixed/other/undifferentiated (vs. serous) | −0.40 | 0.07 | −0.08 | 0.68 |
| Stage 3–4 (vs. 1–2) | 0.80 | <0.0001 | ||
| Ascites (any vs. none) | 1.36 | <0.0001 | ||